Diffusion Pharmaceuticals Inc.

NasdaqCM:DFFN Stock Report

Mkt Cap: US$12.7m

Diffusion Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of DFFN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,5920.2%
Institutions194,9409.6%
General Public1,839,90990.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 23 shareholders own 9.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.57%
The Vanguard Group, Inc.
72,721$453.8k-9.06%no data
2.16%
Renaissance Technologies LLC
44,009$274.6k-9.77%no data
1.61%
BlackRock, Inc.
32,852$205.0k0%no data
0.84%
Geode Capital Management, LLC
17,165$107.1k0%no data
0.81%
Bridgeway Capital Management, LLC
16,565$103.4k0%no data
0.37%
Dimensional Fund Advisors LP
7,451$46.5k-0.64%no data
0.098%
Tower Research Capital LLC
1,998$12.5k715.51%no data
0.069%
Robert Cobuzzi
1,410$8.8k17.11%no data
0.053%
Mark Giles
1,076$6.7k0%no data
0.049%
Jane Hollingsworth
1,001$6.2k12.98%no data
0.042%
UBS Asset Management
856$5.3k99.07%no data
0.029%
Christopher Galloway
600$3.7k0%no data
0.028%
Securities America Advisors, Inc.
573$3.6k0%no data
0.027%
Morgan Stanley, Investment Banking and Brokerage Investments
548$3.4k0%no data
0.02%
William Elder
400$2.5k0%no data
0.0055%
Wells Fargo & Company, Securities and Brokerage Investments
112$698.90%no data
0.0035%
Robert Adams
72$449.30%no data
0.002%
Strategic Asset Management, LLC.
40$249.60%no data
0.0016%
Alan Levin
33$205.90%no data
0.00093%
Royal Alliance Associates, Inc., Securities Investments
19$118.60%no data
0.00069%
Wells Fargo & Company, Private Banking and Investment Banking Arm
14$87.40%no data
0.00044%
Coastal Capital Group, Inc.
9$56.20%no data
0.00039%
FSC Securities Corporation, Asset Management Arm
8$49.90%no data